A Phase 2a, Prospective, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Assess the Safety, Tolerability and Evidence of Activity of a Single Intravitreal Injection of UBX1325 in Patients with nAMD
Research Grant
Administered By
Ophthalmology
Awarded By
UNITY Biotechnology
Start Date
November 1, 2021
End Date
November 30, 2023
Administered By
Ophthalmology
Awarded By
UNITY Biotechnology
Start Date
November 1, 2021
End Date
November 30, 2023